F-group (family)
2007.15.1.1 Rib_hydrolayse
Ligands and drugs
222
Member domains
182
with ligand contacts (≤ 4 Å)
82.0% of members
178
with DrugDomain annotations
80.2% of members
72
with a DrugBank compound
32.4% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2007.15.1.1 belongs to X-group 2007 Flavodoxin-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 77% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02701 | NCA | Nicotinamide | 17 |
| DB03227 | NMN | Nicotinamide Mononucleotide | 9 |
| DB14128 | NAD | Nadide | 9 |
| DB00141 | NAG | N-Acetylglucosamine | 4 |
| DB04137 | GTP | Guanosine-5'-Triphosphate | 3 |
| DB02930 | AGS | Adenosine 5'-[gamma-thio]triphosphate | 2 |
| DB03732 | ENP | Etheno-Nadp | 2 |
| DB04145 | PYF | Nicotinyl alcohol | 2 |
| DB02483 | — | Etheno-NAD | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| AVU | [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl[(2R,3R,4R)-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate | 34 |
| NCA | NICOTINAMIDE | 17 |
| AV1 | [(2R,3S,4R,5R)-5-(6-amino-8-bromo-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl [(2R,3S,4S)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate | 15 |
| N | ANY 5'-MONOPHOSPHATE NUCLEOTIDE | 11 |
| NAD | NICOTINAMIDE-ADENINE-DINUCLEOTIDE | 9 |
| NMN | BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE | 9 |
| CXR | CYCLIC ADENOSINE DIPHOSPHATE-RIBOSE | 8 |
| RF5 | 2-deoxy-2-fluoro-5-O-phosphono-alpha-D-arabinofuranose | 8 |
| CL | CHLORIDE ION | 6 |
| G2Q | GUANOSINE DIPHOSPHATE RIBOSE | 6 |
| AVW | [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl [(2R,3R,4S)-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate | 5 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 4 |
| NGD | 3-(AMINOCARBONYL)-1-[(2R,3R,4S,5R)-5-({[(S)-{[(S)-{[(2R,3S,4R,5R)-5-(2-AMINO-6-OXO-1,6-DIHYDRO-9H-PURIN-9-YL)-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL]METHOXY}(HYDROXY)PHOSPHORYL]OXY}(HYDROXY)PHOSPHORYL]OXY}METHYL)-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL]PYRIDINIUM | 4 |
| 2NF | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl][(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1yl)- 3-fluoro-,4- hydroxyoxolan-2-yl]methyl phosphate | 3 |
| DN4 | [[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-oxidanyl-4-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl][(2R,3S,4R,5R)-5-(3-carboxypyridin-1-ium-1-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl phosphate | 3 |
| Kmetal | POTASSIUM ION | 3 |
| N1C | N1-CYCLIC INOSINE 5'-DIPHOSPHORIBOSE | 3 |
| 27C | 5-O-[(S)-butoxy(hydroxy)phosphoryl]-2-deoxy-2-fluoro-alpha-D-arabinofuranose | 2 |
| 46Z | (2R,3R,4S,5S)-4-fluoro-3,5-dihydroxytetrahydrofuran-2-yl 2-phenylethyl hydrogen (S)-phosphate | 2 |
| 48Z | 2-deoxy-2-fluoro-5-O-thiophosphono-alpha-D-arabinofuranose | 2 |